P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial
Titel:
P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial
Auteur:
Galligioni, E. Cetto, G. Nascimben, O. Buonadonna, A. Crivellari, D. Molino, A. Veronesi, A. Graiff, C. Barni, S. Puccetti, C. Ferrazzi, E. Recaldin, E. Sava, C. Saracchini, S. Sacco, C.